Frontiers in Immunology | Cancer Immunity and Immunotherapy

Case Report

Published on 10 Apr 2025

Case Report: Durable remission after abscopal effect following transcatheter hepatic arterial embolization in a patient with mucosal melanoma refractory to immunotherapy

in Cancer Immunity and Immunotherapy

Lynsey M. Claus
Hannah E. Kostan
Marshall E. Hicks
Rony Avritscher
Michael A. Davies

Frontiers in Immunology

doi 10.3389/fimmu.2025.1565355

260 views

Original Research

Published on 10 Apr 2025

Comprehensive pan-cancer analysis identifies PLAG1 as a key regulator of tumor immune microenvironment and prognostic biomarker

in Cancer Immunity and Immunotherapy

Ruicheng Wu
Dengxiong Li
Shuxia Zhang
Jie Wang
Qingxin Yu
Dechao Feng
Ping Han

Frontiers in Immunology

doi 10.3389/fimmu.2025.1572108

241 views

Review

Published on 10 Apr 2025

Glutamine’s double-edged sword: fueling tumor growth and offering therapeutic hope

in Cancer Immunity and Immunotherapy

Liguang Fang
Dandan Gao
Zuomin Jiang
Guoliang Li
Ming Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1578940

170 views

Original Research

Published on 10 Apr 2025

Interaction between post-tumor inflammation and vascular smooth muscle cell dysfunction in sepsis-induced cardiomyopathy

in Cancer Immunity and Immunotherapy

Rui Liu
Lina Jia
Lin Yu
Detian Lai
Qingzhu Li
Bingyu Zhang
Enwei Guo
Kailiang Xu
Qiancheng Luo

Frontiers in Immunology

doi 10.3389/fimmu.2025.1560717

260 views

Study Protocol

Published on 10 Apr 2025

Perioperative the BTLA inhibitor (tifcemalimab) combined with toripalimab and chemotherapy for resectable locally advanced thoracic esophageal squamous cell carcinoma trial (BT-NICE trial): a prospective, single-arm, exploratory study

in Cancer Immunity and Immunotherapy

Chengzhi Ding
Yahao Zhang
Tian Xia
Jiwei Li
Wenjian Yao
Quan Zhang
Zhijun Han
Jianjun Wang
Zhikun Cao
Jinlong Hu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1542877

205 views

Original Research

Accepted on 09 Apr 2025

Pan-Cancer Analysis of Phagocytosis Regulators in Female-Specific Cancers: A Focus on HMGB2

in Cancer Immunity and Immunotherapy

Xiaoqin Lu
Dan Ren
Panpan Zhao
Yanfang Li
Zhenhui Wang
Jingyan Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1565924

Case Report

Accepted on 09 Apr 2025

A novel chemotherapy-free regimen combined with photodynamic therapy, target therapy, and immunotherapy in a geriatric male with huge recurrent scalp and facial angiosarcoma: a report of an extremely rare case and literature review

in Cancer Immunity and Immunotherapy

Hao Chen
Ewetse Paul Maswikiti
Zedong Feng
Fan Zhang
Lijuan He
Baohong Gu
Xiang Lin
Huixia Li
Caijuan Wang
Yang Yu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1556493

Systematic Review

Accepted on 09 Apr 2025

Global research status and frontiers on ferroptosis in hepatocellular carcinoma: a comprehensive bibliometric and visualized analysis

in Cancer Immunity and Immunotherapy

Jiayu Zhu
Shengping Luo
Fei Yu
Kewei Sun

Frontiers in Immunology

doi 10.3389/fimmu.2025.1549600

Review

Accepted on 09 Apr 2025

Histone modifications and metabolic reprogramming in Tumor-associated macrophages: a potential target of tumor immunotherapy

in Cancer Immunity and Immunotherapy

Yiting Xu
Han Zhang
Nie Dengyun

Frontiers in Immunology

doi 10.3389/fimmu.2025.1521550

Original Research

Published on 09 Apr 2025

Exploring the role of LOX family in glioma progression and immune modulation

in Cancer Immunity and Immunotherapy

Chen Liu
Huilian Qiao
Hongqi Li
Xiaolong Hu
Maohui Yan
Zhiguang Fu
Hengheng Zhang
Yingjie Wang
Nan Du

Frontiers in Immunology

doi 10.3389/fimmu.2025.1512186

268 views

Case Report

Published on 09 Apr 2025

Case Report: Rapid response to gemtuzumab-ozogamicin in a pediatric patient with refractory systemic mastocytosis with AML1::ETO+ acute myeloid leukemia

in Cancer Immunity and Immunotherapy

Song Xue
Man Chen
Hui-Peng Sun
Tong Wang
Li-Na Zhang
Xing-Yu Cao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1566805

190 views

Original Research

Published on 09 Apr 2025

Investigation of the role of GEM in systemic lupus erythematosus through multi-omics joint analysis

in Cancer Immunity and Immunotherapy

Ruofei Chen
Xiao Zhang
Yifang Shang
Huaixuan Zhang
Xiaolei Li
Hanren Dai
Zongwen Shuai

Frontiers in Immunology

doi 10.3389/fimmu.2025.1569605

221 views

Review

Published on 09 Apr 2025

Gemcitabine: immunomodulatory or immunosuppressive role in the tumor microenvironment

in Cancer Immunity and Immunotherapy

Mahnaz Nemati
Chou-Yi Hsu
Deepak Nathiya
M. Ravi Kumar
Enwa Felix Oghenemaro
Muthena Kariem
Parjinder Kaur
Deepak Bhanot
Ahmed Hjazi
Tayebeh Azam Saedi

Frontiers in Immunology

doi 10.3389/fimmu.2025.1536428

316 views

Original Research

Published on 09 Apr 2025

Epithelial and macrophage cell interaction in cervical cancer through single-cell RNA-sequencing and spatial analysis

in Cancer Immunity and Immunotherapy

Zhichao Wang
Long Cheng
Guanghui Li
Huiyan Cheng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1537785

242 views

Original Research

Published on 09 Apr 2025

Breaking barriers: harnessing hypofractionated radiotherapy to transform outcomes in low tumor mutation burden stage III non-small cell lung cancer - a retrospective study

in Cancer Immunity and Immunotherapy

Jingyun Yang
Tianxiang Cui
Yang Zhang
Guangpeng Chen
Xinxin Wang
Jianguo Sun
Anmei Zhang
Guanghui Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1557154

247 views

Original Research

Accepted on 08 Apr 2025

IFN-γ-mediated suppression of ANGPT2-Tie2 in endothelial cells facilitates tumor vascular normalization during immunotherapy

in Cancer Immunity and Immunotherapy

Zihao Cai
KELIN MENG
Taiyan Yu
Yu Xi
Zhiwei Yuan
Xue Wang
Congjian Wang
Lequn Li
Xiangning Fu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1551322

105 views